大连理工大学主页平台管理系统 Xemnas Cell adhesion molecule ITGB2 promotes CAR-T cell therapy in B-cell malignancies Home

Xemnas

+

Doctoral Degree

Recommended MA Supervisor

Personal Information

Gender:Male
Date of Birth:1988-04-20
Business Address:大连理工大学附属肿瘤医院（辽宁省肿瘤医院）沈抚院区6号楼8楼
E-Mail:

Other Contact Information

个人主页 :

电子邮箱 :

联系电话 :

Home > Scientific Research > Paper Publications

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the "all-around warrior" in immunotherapy

Release Time:2025-10-28 Hits:

Date of Publication: 2024-11-23
Journal: MOLECULAR CANCER
Volume: 23
Issue: 1
Key Words: BLADDER-CANCER; EFFICACY; EMERGING ROLE; IMMUNE ESCAPE; NITROXOLINE; PD-L1 EXPRESSION; PEMBROLIZUMAB; RENAL-CELL CARCINOMA; RESISTANCE MECHANISMS; T-CELLS

Prev One:Innovations in three-dimensional-printed individualized bone prosthesis materials: revolutionizing orthopedic surgery: a review

Next One:Critique of CSPH impact on HCC surgical outcomes

Home

Scientific Research

Teaching Research

Awards and Honours

Enrollment Information

Student Information

Recommended MA Supervisor

Personal Information

Other Contact Information

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the "all-around warrior" in immunotherapy